Biogen Beats

Biogen (BIIB) reported 2nd Quarter June 2025 earnings of $5.47 per share on revenue of $2.6 billion. The consensus earnings estimate was $3.93 per share on revenue of $2.3 billion. The Earnings Whisper number was $3.85 per share. Revenue grew 7.3% on a year-over-year basis.

Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.